GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beryl Drugs Ltd (BOM:524606) » Definitions » Price-to-Free-Cash-Flow

Beryl Drugs (BOM:524606) Price-to-Free-Cash-Flow : N/A (As of Jun. 10, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Beryl Drugs Price-to-Free-Cash-Flow?

As of today (2024-06-10), Beryl Drugs's share price is ₹36.57. Beryl Drugs's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00. Hence, Beryl Drugs's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Beryl Drugs's Price-to-Free-Cash-Flow or its related term are showing as below:

BOM:524606' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 0   Max: 24.12
Current: 19.99

During the past 13 years, Beryl Drugs's highest Price-to-Free-Cash-Flow Ratio was 24.12. The lowest was 0.00. And the median was 0.00.

BOM:524606's Price-to-Free-Cash-Flow is ranked better than
53.5% of 529 companies
in the Drug Manufacturers industry
Industry Median: 22.78 vs BOM:524606: 19.99

Beryl Drugs's Free Cash Flow per Share for the three months ended in Mar. 2024 was ₹0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₹0.00.

During the past 13 years, Beryl Drugs's highest 3-Year average Free Cash Flow per Share Growth Rate was 148.40% per year. The lowest was -73.30% per year. And the median was 10.80% per year.


Beryl Drugs Price-to-Free-Cash-Flow Historical Data

The historical data trend for Beryl Drugs's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beryl Drugs Price-to-Free-Cash-Flow Chart

Beryl Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 6.73 -

Beryl Drugs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.73 - - - -

Competitive Comparison of Beryl Drugs's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Beryl Drugs's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beryl Drugs's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beryl Drugs's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Beryl Drugs's Price-to-Free-Cash-Flow falls into.



Beryl Drugs Price-to-Free-Cash-Flow Calculation

Beryl Drugs's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=36.57/0
=N/A

Beryl Drugs's Share Price of today is ₹36.57.
Beryl Drugs's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Beryl Drugs  (BOM:524606) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Beryl Drugs Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Beryl Drugs's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Beryl Drugs (BOM:524606) Business Description

Traded in Other Exchanges
N/A
Address
133, Kanchan Bagh, Ground Floor, Indore, MP, IND, 452001
Beryl Drugs Ltd is a pharmaceutical company principally engaged in the manufacturing and marketing of allopathic pharmaceutical preparations. It also provides contract manufacturing services and veterinary products. It offers manufacturing options for product requirements like small-volume injectables in liquid form, small-volume injectables in dry powder form, eye and ear drops, intravenous fluids in poly pack and glass bottles, and veterinary medicines. The company earns the majority of its revenue from the sale of Bulk Drugs.

Beryl Drugs (BOM:524606) Headlines

No Headlines